- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Pneumonia Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Pneumonia Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pneumonia accounting for % of the Pneumonia Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Pneumococcal Conjugate Vaccine (PCV13) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pneumonia Vaccine include Pfizer Inc., Glaxosmithkline Plc., Merck & Co., Inc., Sanofi Pasteur, and Serum Institute of India Pvt. Ltd., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pneumonia Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Other
Market segment by Application can be divided into
Pneumonia
Meningitis
Sepsis
The key market players for global Pneumonia Vaccine market are listed below:
Pfizer Inc.
Glaxosmithkline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Astrazeneca Plc.
CSL Limited
Emergent Biosolutions
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pneumonia Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pneumonia Vaccine, with price, sales, revenue and global market share of Pneumonia Vaccine from 2019 to 2022.
Chapter 3, the Pneumonia Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumonia Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pneumonia Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pneumonia Vaccine.
Chapter 13, 14, and 15, to describe Pneumonia Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Pneumonia Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pneumonia Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Pneumonia Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Sepsis
1.4 Global Pneumonia Vaccine Market Size & Forecast
1.4.1 Global Pneumonia Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pneumonia Vaccine Sales in Volume (2017-2028)
1.4.3 Global Pneumonia Vaccine Price (2017-2028)
1.5 Global Pneumonia Vaccine Production Capacity Analysis
1.5.1 Global Pneumonia Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Pneumonia Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pneumonia Vaccine Market Drivers
1.6.2 Pneumonia Vaccine Market Restraints
1.6.3 Pneumonia Vaccine Trends Analysis
2 Manufacturers Profiles
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business
2.1.3 Pfizer Inc. Pneumonia Vaccine Product and Services
2.1.4 Pfizer Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Glaxosmithkline Plc.
2.2.1 Glaxosmithkline Plc. Details
2.2.2 Glaxosmithkline Plc. Major Business
2.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Product and Services
2.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck & Co., Inc.
2.3.1 Merck & Co., Inc. Details
2.3.2 Merck & Co., Inc. Major Business
2.3.3 Merck & Co., Inc. Pneumonia Vaccine Product and Services
2.3.4 Merck & Co., Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofi Pasteur
2.4.1 Sanofi Pasteur Details
2.4.2 Sanofi Pasteur Major Business
2.4.3 Sanofi Pasteur Pneumonia Vaccine Product and Services
2.4.4 Sanofi Pasteur Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Serum Institute of India Pvt. Ltd.
2.5.1 Serum Institute of India Pvt. Ltd. Details
2.5.2 Serum Institute of India Pvt. Ltd. Major Business
2.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product and Services
2.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Pneumonia Vaccine Product and Services
2.6.4 Johnson & Johnson Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Astellas Pharma Inc.
2.7.1 Astellas Pharma Inc. Details
2.7.2 Astellas Pharma Inc. Major Business
2.7.3 Astellas Pharma Inc. Pneumonia Vaccine Product and Services
2.7.4 Astellas Pharma Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Astrazeneca Plc.
2.8.1 Astrazeneca Plc. Details
2.8.2 Astrazeneca Plc. Major Business
2.8.3 Astrazeneca Plc. Pneumonia Vaccine Product and Services
2.8.4 Astrazeneca Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 CSL Limited
2.9.1 CSL Limited Details
2.9.2 CSL Limited Major Business
2.9.3 CSL Limited Pneumonia Vaccine Product and Services
2.9.4 CSL Limited Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Emergent Biosolutions
2.10.1 Emergent Biosolutions Details
2.10.2 Emergent Biosolutions Major Business
2.10.3 Emergent Biosolutions Pneumonia Vaccine Product and Services
2.10.4 Emergent Biosolutions Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Walvax Biotechnology
2.11.1 Walvax Biotechnology Details
2.11.2 Walvax Biotechnology Major Business
2.11.3 Walvax Biotechnology Pneumonia Vaccine Product and Services
2.11.4 Walvax Biotechnology Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Royal (Wuxi) Bio-Pharmaceutical
2.12.1 Royal (Wuxi) Bio-Pharmaceutical Details
2.12.2 Royal (Wuxi) Bio-Pharmaceutical Major Business
2.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product and Services
2.12.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Zhifei Biologic
2.13.1 Zhifei Biologic Details
2.13.2 Zhifei Biologic Major Business
2.13.3 Zhifei Biologic Pneumonia Vaccine Product and Services
2.13.4 Zhifei Biologic Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pneumonia Vaccine Breakdown Data by Manufacturer
3 Pneumonia Vaccine Breakdown Data by Manufacturer
3.1 Global Pneumonia Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pneumonia Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pneumonia Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Pneumonia Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Pneumonia Vaccine Manufacturer Market Share in 2021
3.5 Global Pneumonia Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pneumonia Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4 Market Analysis by Region
4.1 Global Pneumonia Vaccine Market Size by Region
4.1.1 Global Pneumonia Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Pneumonia Vaccine Revenue by Region (2017-2028)
4.2 North America Pneumonia Vaccine Revenue (2017-2028)
4.3 Europe Pneumonia Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Pneumonia Vaccine Revenue (2017-2028)
4.5 South America Pneumonia Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Pneumonia Vaccine Revenue (2017-2028)
5 Market Segment by Type
5 Market Segment by Type
5.1 Global Pneumonia Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Pneumonia Vaccine Revenue by Type (2017-2028)
5.3 Global Pneumonia Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6 Market Segment by Application
6.1 Global Pneumonia Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Pneumonia Vaccine Revenue by Application (2017-2028)
6.3 Global Pneumonia Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7 North America by Country, by Type, and by Application
7.1 North America Pneumonia Vaccine Sales by Type (2017-2028)
7.2 North America Pneumonia Vaccine Sales by Application (2017-2028)
7.3 North America Pneumonia Vaccine Market Size by Country
7.3.1 North America Pneumonia Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Pneumonia Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8 Europe by Country, by Type, and by Application
8.1 Europe Pneumonia Vaccine Sales by Type (2017-2028)
8.2 Europe Pneumonia Vaccine Sales by Application (2017-2028)
8.3 Europe Pneumonia Vaccine Market Size by Country
8.3.1 Europe Pneumonia Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Pneumonia Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pneumonia Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Pneumonia Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Pneumonia Vaccine Market Size by Region
9.3.1 Asia-Pacific Pneumonia Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pneumonia Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10 South America by Region, by Type, and by Application
10.1 South America Pneumonia Vaccine Sales by Type (2017-2028)
10.2 South America Pneumonia Vaccine Sales by Application (2017-2028)
10.3 South America Pneumonia Vaccine Market Size by Country
10.3.1 South America Pneumonia Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Pneumonia Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pneumonia Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Pneumonia Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Pneumonia Vaccine Market Size by Country
11.3.1 Middle East & Africa Pneumonia Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pneumonia Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12 Raw Material and Industry Chain
12.1 Raw Material of Pneumonia Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pneumonia Vaccine
12.3 Pneumonia Vaccine Production Process
12.4 Pneumonia Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pneumonia Vaccine Typical Distributors
13.3 Pneumonia Vaccine Typical Customers
14 Research Findings and Conclusion
14 Research Findings and Conclusion
15 Appendix
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Pneumonia Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pneumonia Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Inc. Major Business
Table 5. Pfizer Inc. Pneumonia Vaccine Product and Services
Table 6. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Glaxosmithkline Plc. Basic Information, Manufacturing Base and Competitors
Table 8. Glaxosmithkline Plc. Major Business
Table 9. Glaxosmithkline Plc. Pneumonia Vaccine Product and Services
Table 10. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Merck & Co., Inc. Major Business
Table 13. Merck & Co., Inc. Pneumonia Vaccine Product and Services
Table 14. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Pasteur Major Business
Table 17. Sanofi Pasteur Pneumonia Vaccine Product and Services
Table 18. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. Serum Institute of India Pvt. Ltd. Major Business
Table 21. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product and Services
Table 22. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 24. Johnson & Johnson Major Business
Table 25. Johnson & Johnson Pneumonia Vaccine Product and Services
Table 26. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Astellas Pharma Inc. Major Business
Table 29. Astellas Pharma Inc. Pneumonia Vaccine Product and Services
Table 30. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Astrazeneca Plc. Basic Information, Manufacturing Base and Competitors
Table 32. Astrazeneca Plc. Major Business
Table 33. Astrazeneca Plc. Pneumonia Vaccine Product and Services
Table 34. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 36. CSL Limited Major Business
Table 37. CSL Limited Pneumonia Vaccine Product and Services
Table 38. CSL Limited Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 40. Emergent Biosolutions Major Business
Table 41. Emergent Biosolutions Pneumonia Vaccine Product and Services
Table 42. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 44. Walvax Biotechnology Major Business
Table 45. Walvax Biotechnology Pneumonia Vaccine Product and Services
Table 46. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Royal (Wuxi) Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Royal (Wuxi) Bio-Pharmaceutical Major Business
Table 49. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product and Services
Table 50. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Zhifei Biologic Basic Information, Manufacturing Base and Competitors
Table 52. Zhifei Biologic Major Business
Table 53. Zhifei Biologic Pneumonia Vaccine Product and Services
Table 54. Zhifei Biologic Pneumonia Vaccine Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Pneumonia Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 56. Global Pneumonia Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Pneumonia Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Pneumonia Vaccine Production Capacity by Company, (K Doses): 2020 VS 2021
Table 59. Head Office and Pneumonia Vaccine Production Site of Key Manufacturer
Table 60. Pneumonia Vaccine New Entrant and Capacity Expansion Plans
Table 61. Pneumonia Vaccine Mergers & Acquisitions in the Past Five Years
Table 62. Global Pneumonia Vaccine Sales by Region (2017-2022) & (K Doses)
Table 63. Global Pneumonia Vaccine Sales by Region (2023-2028) & (K Doses)
Table 64. Global Pneumonia Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Pneumonia Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 67. Global Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 68. Global Pneumonia Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Pneumonia Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Pneumonia Vaccine Price by Type (2017-2022) & (USD/Dose)
Table 71. Global Pneumonia Vaccine Price by Type (2023-2028) & (USD/Dose)
Table 72. Global Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 73. Global Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 74. Global Pneumonia Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Pneumonia Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Pneumonia Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 77. Global Pneumonia Vaccine Price by Application (2023-2028) & (USD/Dose)
Table 78. North America Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 79. North America Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 80. North America Pneumonia Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Pneumonia Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 83. North America Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 84. North America Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 85. North America Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 86. Europe Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 87. Europe Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 88. Europe Pneumonia Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Pneumonia Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 91. Europe Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 92. Europe Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 93. Europe Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 94. Asia-Pacific Pneumonia Vaccine Sales by Region (2017-2022) & (K Doses)
Table 95. Asia-Pacific Pneumonia Vaccine Sales by Region (2023-2028) & (K Doses)
Table 96. Asia-Pacific Pneumonia Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Pneumonia Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 99. Asia-Pacific Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 100. Asia-Pacific Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 101. Asia-Pacific Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 102. South America Pneumonia Vaccine Sales by Country (2017-2022) & (K Doses)
Table 103. South America Pneumonia Vaccine Sales by Country (2023-2028) & (K Doses)
Table 104. South America Pneumonia Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Pneumonia Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 107. South America Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 108. South America Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 109. South America Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 110. Middle East & Africa Pneumonia Vaccine Sales by Region (2017-2022) & (K Doses)
Table 111. Middle East & Africa Pneumonia Vaccine Sales by Region (2023-2028) & (K Doses)
Table 112. Middle East & Africa Pneumonia Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Pneumonia Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Pneumonia Vaccine Sales by Type (2017-2022) & (K Doses)
Table 115. Middle East & Africa Pneumonia Vaccine Sales by Type (2023-2028) & (K Doses)
Table 116. Middle East & Africa Pneumonia Vaccine Sales by Application (2017-2022) & (K Doses)
Table 117. Middle East & Africa Pneumonia Vaccine Sales by Application (2023-2028) & (K Doses)
Table 118. Pneumonia Vaccine Raw Material
Table 119. Key Manufacturers of Pneumonia Vaccine Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Pneumonia Vaccine Typical Distributors
Table 123. Pneumonia Vaccine Typical Customers
List of Figures
Figure 1. Pneumonia Vaccine Picture
Figure 2. Global Pneumonia Vaccine Revenue Market Share by Type in 2021
Figure 3. Pneumococcal Conjugate Vaccine (PCV13)
Figure 4. Pneumococcal Polysaccharide Vaccine (PPSV23)
Figure 5. Other
Figure 6. Global Pneumonia Vaccine Revenue Market Share by Application in 2021
Figure 7. Pneumonia
Figure 8. Meningitis
Figure 9. Sepsis
Figure 10. Global Pneumonia Vaccine Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 11. Global Pneumonia Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Pneumonia Vaccine Sales (2017-2028) & (K Doses)
Figure 13. Global Pneumonia Vaccine Price (2017-2028) & (USD/Dose)
Figure 14. Global Pneumonia Vaccine Production Capacity (2017-2028) & (K Doses)
Figure 15. Global Pneumonia Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Pneumonia Vaccine Market Drivers
Figure 17. Pneumonia Vaccine Market Restraints
Figure 18. Pneumonia Vaccine Market Trends
Figure 19. Global Pneumonia Vaccine Sales Market Share by Manufacturer in 2021
Figure 20. Global Pneumonia Vaccine Revenue Market Share by Manufacturer in 2021
Figure 21. Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Pneumonia Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Pneumonia Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Pneumonia Vaccine Sales Market Share by Region (2017-2028)
Figure 25. Global Pneumonia Vaccine Revenue Market Share by Region (2017-2028)
Figure 26. North America Pneumonia Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Europe Pneumonia Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Pneumonia Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. South America Pneumonia Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Pneumonia Vaccine Revenue (2017-2028) & (USD Million)
Figure 31. Global Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 32. Global Pneumonia Vaccine Revenue Market Share by Type (2017-2028)
Figure 33. Global Pneumonia Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 34. Global Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 35. Global Pneumonia Vaccine Revenue Market Share by Application (2017-2028)
Figure 36. Global Pneumonia Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 37. North America Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 38. North America Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 39. North America Pneumonia Vaccine Sales Market Share by Country (2017-2028)
Figure 40. North America Pneumonia Vaccine Revenue Market Share by Country (2017-2028)
Figure 41. United States Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 45. Europe Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 46. Europe Pneumonia Vaccine Sales Market Share by Country (2017-2028)
Figure 47. Europe Pneumonia Vaccine Revenue Market Share by Country (2017-2028)
Figure 48. Germany Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Pneumonia Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Pneumonia Vaccine Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Pneumonia Vaccine Revenue Market Share by Region (2017-2028)
Figure 57. China Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 64. South America Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 65. South America Pneumonia Vaccine Sales Market Share by Country (2017-2028)
Figure 66. South America Pneumonia Vaccine Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Pneumonia Vaccine Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Pneumonia Vaccine Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Pneumonia Vaccine Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Pneumonia Vaccine Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Pneumonia Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Pneumonia Vaccine in 2021
Figure 78. Manufacturing Process Analysis of Pneumonia Vaccine
Figure 79. Pneumonia Vaccine Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
